As cancer survival rates improve, the "Long-Term Side Effects" of treatment are coming into sharper focus. In 2026, the Peripheral Neuropathy Market is seeing a steady increase in cases of "Chemotherapy-Induced Peripheral Neuropathy" (CIPN). Many life-saving cancer drugs are unfortunately "Neurotoxic," meaning they can damage the nerves in the hands and feet as they fight the tumor. In 2026,...
0 Comments
0 Shares
384 Views
0 Reviews
Sponsored
×
Install Ework Face
Install our app for a better experience, faster access, and offline capabilities.